Lung squamous cell carcinoma: A postoperative recurrence analysis of keratinizing and nonkeratinizing subtypes

被引:6
作者
Chen, Rongrong [1 ]
Yang, Xiaohua [2 ]
Ding, Zhengping [1 ]
Zhu, Lei [3 ]
Lu, Shun [1 ]
Yu, Yongfeng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pathol, 241 West Huaihai Rd, Shanghai 200030, Peoples R China
来源
EJSO | 2019年 / 45卷 / 05期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Lung squamous cell carcinoma; Keratinizing; Nonkeratinizing; Recurrence; VISCERAL PLEURA INVASION; NEVER-SMOKERS; NASOPHARYNGEAL CARCINOMA; LYMPHOVASCULAR INVASION; PROGNOSTIC-SIGNIFICANCE; HISTOLOGIC SUBTYPE; CANCER; SURVIVAL; CLASSIFICATION; RADIOTHERAPY;
D O I
10.1016/j.ejso.2018.10.535
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is currently no definite clinical implication for the subtypes of lung squamous cell carcinoma according to the 2015 WHO classification. This study aimed to investigate postoperative recurrence of the two major subtypes of lung squamous cell carcinoma: keratinizing squamous cell carcinoma (KSCC) and nonkeratinizing squamous cell carcinoma (NKSCC). Methods: We identified the patients with KSCC and NKSCC who had undergone complete resection in Shanghai Chest Hospital between April 2015 and June 2016. Disease-free survival (DFS) was compared using Kaplan-Meier statistical analysis. Variables selected by univariate analysis were evaluated in multivariate analysis using the Cox proportional hazard model. Results: A total of 334 patients included 231 (69.2%) cases with KSCC and 103 (30.8%) cases with NKSCC. There were more smokers in keratinizing than nonkeratinizing subtype (84.8% versus 72.8%, p = 0.009). The percentage of stage III was higher in NKSCC than that in KSCC (35% versus 22.9%, p = 0.012). The 2 year DFS rates of stage I, stage II and stage III were 90.1%, 66.4% and 37.7% in KSCC, 83.3%, 67.7% and 52.8% in NKSCC, respectively. There were no significant differences of 2-year DFS rates between KSCC and NKSCC. Furthermore, KSCC and NKSCC had no significant differences in recurrence patterns and metastatic sites. Conclusion: There were no significant differences of postoperative recurrence between KSCC and NKSCC. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:838 / 844
页数:7
相关论文
共 33 条
  • [11] Postoperative Radiotherapy is Associated with Better Survival in Non-Small Cell Lung Cancer with Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base
    Mikell, John L.
    Gillespie, Theresa W.
    Hall, William A.
    Nickleach, Dana C.
    Liu, Yuan
    Lipscomb, Joseph
    Ramalingam, Suresh S.
    Rajpara, Raj S.
    Force, Seth D.
    Fernandez, Felix G.
    Owonikoko, Taofeek K.
    Pillai, Rathi N.
    Khuri, Fadlo R.
    Curran, Walter J.
    Higgins, Kristin A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (03) : 462 - 471
  • [12] Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Mollberg, Nathan M.
    Bennette, Carrie
    Howell, Eric
    Backhus, Leah
    Devine, Beth
    Ferguson, Mark K.
    [J]. ANNALS OF THORACIC SURGERY, 2014, 97 (03) : 965 - 972
  • [13] Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or Smaller
    Nitadori, Jun-ichi
    Bograd, Adam J.
    Kadota, Kyuichi
    Sima, Camelia S.
    Rizk, Nabil P.
    Morales, Eduardo A.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (16): : 1212 - 1220
  • [14] Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology
    Ou, S. -H. I.
    Zell, J. A.
    Ziogas, A.
    Anton-Culver, H.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (01) : 29 - 35
  • [15] EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    Pao, W
    Miller, V
    Zakowski, M
    Doherty, J
    Politi, K
    Sarkaria, I
    Singh, B
    Heelan, R
    Rusch, V
    Fulton, L
    Mardis, E
    Kupfer, D
    Wilson, R
    Kris, M
    Varmus, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) : 13306 - 13311
  • [16] PROGNOSTIC-SIGNIFICANCE OF KERATINIZATION IN NASOPHARYNGEAL CARCINOMA
    REDDY, SP
    RASLAN, WF
    GOONERATNE, S
    KATHURIA, S
    MARKS, JE
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1995, 16 (02) : 103 - 108
  • [17] Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
    Scagliotti, Giorgio Vittorio
    Parikh, Purvish
    von Pawel, Joachim
    Biesma, Bonne
    Vansteenkiste, Johan
    Manegold, Christian
    Serwatowski, Piotr
    Gatzemeier, Ulrich
    Digumarti, Raghunadharao
    Zukin, Mauro
    Lee, Jin S.
    Mellemgaard, Anders
    Park, Keunchil
    Patil, Shehkar
    Rolski, Janusz
    Goksel, Tuncay
    de Marinis, Filippo
    Simms, Lorinda
    Sugarman, Katherine P.
    Gandara, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3543 - 3551
  • [18] Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial
    Shen, Wen-yi
    Ji, Jian
    Zuo, Yang-song
    Pu, Juan
    Xu, Yan-mei
    Zong, Cheng-dong
    Tao, Guang-zhou
    Chen, Xiao-fei
    Ji, Fu-zhi
    Zhou, Xi-lei
    Han, Ji-hua
    Wang, Cheng-shi
    Yi, Jiang-guo
    Su, Xi-long
    Zhu, Wei-guo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) : 120 - 125
  • [19] Visceral pleural invasion classification in non-small cell lung cancer: A proposal on the basis of outcome assessment
    Shimizu, K
    Yoshida, J
    Nagai, K
    Nishimura, M
    Yokose, T
    Ishii, G
    Nishiwaki, Y
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (06) : 1574 - 1578
  • [20] Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer
    Socinski, Mark A.
    Novello, Silvia
    Brahmer, Julie R.
    Rosell, Rafael
    Sanchez, Jose M.
    Belani, Chandra P.
    Govindan, Ramaswamy
    Atkins, James N.
    Gillenwater, Heidi H.
    Pallares, Cinta
    Tye, Lesley
    Selaru, Paulina
    Chao, Richard C.
    Scagliotti, Giorgio V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 650 - 656